Background: Cohort studies have demonstrated an association between C-reactive protein (CRP) and interleukin-6 (IL- 6) and all-cause and cardiovascular mortality in end-stage renal disease (ESRD) patients. Interleukin-8 ( IL-8) appears to be not only the plasma expression of the acute-phase response but also a direct pathogenetic mediator of the atherosclerotic process. Methods: To evaluate the role of IL-8 in predicting outcome, 76 chronic dialytic patients were prospectively followed for 18 months. At baseline, blood samples were taken for analysis of high-sensitivity CRP, IL- 6, IL- 8 and other standard laboratory analyses. Results: Median IL- 8 was 5.2 mg/l, therefore near half of the patients had IL-8 values within the range of 'normal...
BACKGROUND: In chronic hemodialysis (HD) patients, the repetitive induction of the acute phase respo...
C-reactive protein (CRP) is considered to be the prototype marker of inflammation. In the general po...
Background and objectives: Inflammation-induced atherosclerosis and enhanced susceptibility to infec...
Background. Despite the well known association between interleukin-6 (IL-6) and cardiovascular morta...
Chronic inflammation associated with chronic kidney disease predicts all-cause and cardiovascular mo...
Chronic inflammation associated with chronic kidney disease predicts all-cause and cardiovascular mo...
Mortality, malnutrition, and atherosclerosis in ESRD: What is the role of interleukin-6? There is gr...
Background: The utility of local and systemic interleukin 6 (IL-6) as a prognostic marker in inciden...
Inflammation and cardiovascular risk in dialysis patients.BackgroundChronic inflammation, as evidenc...
BACKGROUND: Morbidity and mortality rates are high among patients with end-stage renal disease (ESRD...
Abstract Background Systemic inflammation, measured as circulating Interleukin-6 (IL-6) levels, is a...
End-stage kidney disease increases mortality and the risk of cardiovascular (CV) disease. It is cruc...
Plasma cytokine levels predict mortality in patients with acute renal failure.BackgroundCritically i...
♦ Background: The utility of local and systemic interleu-kin 6 (IL-6) as a prognostic marker in inci...
BACKGROUND: Several studies have provided convincing evidence that in apparently healthy subjects el...
BACKGROUND: In chronic hemodialysis (HD) patients, the repetitive induction of the acute phase respo...
C-reactive protein (CRP) is considered to be the prototype marker of inflammation. In the general po...
Background and objectives: Inflammation-induced atherosclerosis and enhanced susceptibility to infec...
Background. Despite the well known association between interleukin-6 (IL-6) and cardiovascular morta...
Chronic inflammation associated with chronic kidney disease predicts all-cause and cardiovascular mo...
Chronic inflammation associated with chronic kidney disease predicts all-cause and cardiovascular mo...
Mortality, malnutrition, and atherosclerosis in ESRD: What is the role of interleukin-6? There is gr...
Background: The utility of local and systemic interleukin 6 (IL-6) as a prognostic marker in inciden...
Inflammation and cardiovascular risk in dialysis patients.BackgroundChronic inflammation, as evidenc...
BACKGROUND: Morbidity and mortality rates are high among patients with end-stage renal disease (ESRD...
Abstract Background Systemic inflammation, measured as circulating Interleukin-6 (IL-6) levels, is a...
End-stage kidney disease increases mortality and the risk of cardiovascular (CV) disease. It is cruc...
Plasma cytokine levels predict mortality in patients with acute renal failure.BackgroundCritically i...
♦ Background: The utility of local and systemic interleu-kin 6 (IL-6) as a prognostic marker in inci...
BACKGROUND: Several studies have provided convincing evidence that in apparently healthy subjects el...
BACKGROUND: In chronic hemodialysis (HD) patients, the repetitive induction of the acute phase respo...
C-reactive protein (CRP) is considered to be the prototype marker of inflammation. In the general po...
Background and objectives: Inflammation-induced atherosclerosis and enhanced susceptibility to infec...